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H1044106 IsContinuousSTMonitoringsBetterPredictorOutcomeThsnEnroiiingEiectrocardiogrsmin
AcuteMyocerdiainfarction?
R.E. Boinaeu, C.L. Green, K.M. Trollinger, J.E. Pope, E.J. Topol, R.M. Califf,
M.W. Krucoff. DukeUniveraifyMedicalCentecDurham,NC,USA
The GUSTO-1trial showad that certain enrollment variables predict 30-day
mortality after Ml. Peak lead ST elevation (STPK) on enrollment ECG was
not predictive, though thia is the variable that drives treatment. We theorized
that the peak was not obtained on the static enrollment ECG, with loss of
predictive information. We evaluated peak ST elevation on enrollment ECG
vs peak ST elevation in the primaty lead during continuous (CONT) 12-
Iead ST monitoring in the GUSTO-1and TAMI-9 acute Ml substudies, using
patients as their own mntrols (N = 492). Endpoints were combined death or
new CHF, or no death or CHF at 30 days. No significant differences in age,
sex, prior Ml, hypertension, smoking, diabetes, peak CK, time to treatment
(TIT) or ejection fraction (EF) were seen. Results were:
Death Peak llT Lyticsto Enrollment CONT
CHF N CK hrs EF STPKa STPKb STPKC STPl@
Yes 140 2200 2.8 80 (0-83) 40,0 325 IJV 525 /JV
No 352 1233 2.7 55 (0-29) 35.8 300 /Jv 434 WV
aRange (rein),bpsrcentPK on enrollECG, Cp= 0.159, dp = 0.0048
Conclusions:Enrollment ECG failed to identify true peak ST in 60% of
AMI pte. There was a trend for later peaks in pts. with poor outcome. Peaks
were identified within the first 6 houra in gs~o of pts. Thus, true ST peak is
predictive of outcome when continuous 12-lead ST monitoring is used.
m1044107 PosteriorChestLeada(W-S)ST~ DuringAcuteinferiorinfarctPredicteLargerinfarctandBettar
BenefitFromThromboiysie
S. Matetsky, G.1.Barabash, D. Freimark, P.Chouraqui, E. Kaplinsky,
H. Hod. Heartlrrstitute,ShebaMedicalCentecTelHashomecIsrael
Since the beneficial effect of thrombolysis is proportional to the amount of
jeopardized myocardium, patients (pts) with inferior myocerdial infarct (lMl)
and posterior involvement may receive greater benefit from thrombolysis than
other IMI pte. However, the early identification of these pts is hampered by
the absence of ST? refiacfing posterior Ml on standard EGG. To determine
the value of ST~ in posterior chest leads (V7--S), to facilitate the diagnosis
of posterior involvement, end to evaluate the effect of thrombolyfic therapy
in this subgroup of IMI pts, we studied 87 pta with first IMI, treated with
rt-PA. Pfawere divided into 2 groups: 46 (53%) with STT in V7._g (Group A)
and 41 (47Yo)without (Group B). Group A had more frequent posterolateral
wall motion abnorrnalitiee on adisaion redionuclide ventriculography (87% vs
46% p < 0.001), higher peak CK (1254 + 873 vs 847 + 723, p < 0.05) and
lower LVEF (53* 14 vs 60 + 9, p < 0.008), than Group B. To determine the
beneficial effect of thrombolysis, pts were atratified according to the patency
of the infarct artery on angiography. While in Group A patency resulted in
better LVEF (58 + 13 ve 44 * 12, p < 0.012), in Group B the EF was
preserved regardless of patency. In conclusion:1) ST~ in V7..g identifies
IMI pts with posterfor involvement. 2) IMI pts with ST? in VT-.-.9benefit more
from thrombolyeis, as compared to those without.
m1044108 ST-segmentEievationin Leadsi andaVLinAcuteAnteroeerMaiMvocardiainfarctionisan
independentRiskFac~orfor LeftVentricular
Rupture
H. Yoshino, K. Yano, K. Sasaki, M. Yotsukura, K. Ishikawa. Kyorin
Univers~,Tokyo,Japan
Background:It is difficuit to determine which patients have a risk of cardiac
rupture after acute myocardial infarction. Objectives:The purpose of this
atudy is to determine the usefulness of electrocardiography (ECG) in the
emergency rcem for assessment of the risk of cardiac rupture after acute
anteroeeptal myocardial infarction (AS-Ml). Methods:The presence of ST-
segment elevations on emergant 12-lead ECGS in 364 consecutive AS-Ml
patients was evaluated. Patients with complete bundle branch block were
excluded. A forward-stepwise logistic regression analysis for cardiac rupture
was performed with covariants of age, gender, and ST-segment elevations
in leads 1,aVL, and VI-V6. Results:Cardiac ruptures were observed in 18
patients, 7 with left ventricular free-wall rupture (FWR) and 9 with ventricular
septal perforation (VSP). For FWR, ST-elevation in lead sVL was the only
independent factor (odds ratio = 5.4, 95% Cl. = 1.6-18.7, P = 0.0078). For
VSP, female gender (odds ratio= 7.7, 95% Cl. = 1.6-33.1, P = 0.0064) and
ST-elevation in lead I (odds ratio = 6.4, 95Y0Cl. = 15--27.5, P = 0.0134)
ware independent factors. For left ventricular cardiac rupture, female gender
(odds ratio = 4.2, 95% C.1= 1.4-12.9, P = 0.0118) and ST-alevation in lead
aVL (odds ratio= 3.5, 95% C.1= 1.6-6.7, P =0.0002) were both independent
factors. Conclusion:In pts with acute AS-Ml, the ST-segment elevation in





A. Natale, K.H. Newby, C. Green, M.W. Krucoff. DukeUniversityMadica/
Center/DudramVAMedicalCentecDurham,NC,USA
The objective of this study was to assess whether continuous 12 lead ECG
ST-segment change8 durfng the first 3 hours of recording could predict or
affect tha occurrence of ventricular fibrillation (VFib) during acuta myocerdial
infarction (Ml) treated with thrombolytic agents. 533 patients undergoing
continuous 12 lead ECG ST sagment monitoring were included in the study.
The variables analyzed included: 1) the time to steady etate of the ST (Time
SS); 2) number of ST transition episodes; 3) the peak of the ST deviation
(ST peak); 4) and the ST curve area (ST area). To evaluate tha effects of
different ST segment transition patterns, patients weredivided as follows: 1)
those with 1 ST transition; 2) those with 2 ST transitions; 3) those with z 3
STtrensitione (cyclic flow). Both patients with and without VFib were equally
distributed in the three groups (p = NS). The remaining ST variables in the
VFib and no VFib groups are shown. Valuas are raported as percentages of
median (25th, 75th) percentiles.
ST Peak ST Arsa Tme SS
VFib = Yes 738 9197 180
Vfib = No 498 4977 124
p Vslue 0.0001 0.0003 0.19
Inconclusion: (1) ST-segmentvariables,looking attheareaof myocerdium
infarcted and at risk, predict VFib in Ml treated with thrombolytic therapy; (2)
frequent episodes of ST segment transition are not associated with either a
higher or lower occurrence of Vfib.
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11045-1101Permanent BiVentriCUiarpaCin9bYa
TransvenousApproach
J.C. Dauber’ t’, S. Cezeau2, P.Ritter2, D. Graa, A. Lazzarusz, J. Mugica2,
P.Mabo 1.1 UrriveraityHospital,Rennes,France,2CentreChirurgicelVal
d’OcSaint-Cloud,France
The banefit of chronic DDD pacing (DDD-P) to treat end-stage congestive
heart failure (CHF) remains controversial. But compared with single right ven-
tricular (RV) DDD-P, biventricular synchronous pacing (BVSP) was recently
shown as cepableto improve symptoms clanshemodynamics in patients with
dilated cardiomyopathy (DCM) and drug-refractory CHF. In the preliminary
repofls, the left ventricle (LV) was paced epicardially. The aim of the present
study was to examined the possibility of performing permanent BVSP with a
totally transvenous lead configuration.
ln24pts, mean age66, avery thin unipolarventricular leadora specifically
designad coronay sinus (CS) lead was introduced into tha CS to catheterize
selectively a cardiac vein over the LV free wall. The tip electrode was intro-
duced ae distally as possible up to a blocked position. The procedure was
successful in 17 pts (72%) with a final placement in the great cardiac veine
(n= 3), ini a Iataral vein (n = 6), in a posterolateral vein (n = 7) and at the LV
apax through the mid-cardiac vein (n = 1). The mean acute pacing thrashold
was 1.2 * 0.S V and the average intracardiac signal amplitude was 15 +
5 mV. The RV lead was placed at the apex or in the outflow tract. The 2
ventricular leads were connected through a Y adaptator to a dual-chamber
(biventricular) pacemaker (PM) in 3 pts, to a ‘Wiple-chamber” PM in 10 pts
and to a “four-chamber” PM in 4 pts.
Aftera mean follow-up of 7 months (2–18), 16 of 17transvenous LV leads
were functional whith a mean chronic pacing threshold of 2.1 + 1 V and an
average intracardiac signal amplitude of 17 * mV. SBVP was effective and
permanent in these 16 pts.
With the currently available lead technology, permanent transvenous LV
